| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/28/2011 | US20110182936 Influenza hemagglutinin and neuraminidase variants |
| 07/28/2011 | US20110182935 Prevention and treatment of sub-clinical pcvd |
| 07/28/2011 | US20110182934 Immune system stimulating nutrition |
| 07/28/2011 | US20110182933 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182932 Modified vaccinia ankara virus variant |
| 07/28/2011 | US20110182931 Immortal avian cell line and methods of use |
| 07/28/2011 | US20110182926 Minigene |
| 07/28/2011 | US20110182925 Ehrlichia canis DIVA (Differentiate Infected from Vaccinated Animals) |
| 07/28/2011 | US20110182924 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 07/28/2011 | US20110182923 Novel group b streptococcus antigens |
| 07/28/2011 | US20110182920 Identification of a novel cysteine-rich cell penetrating peptide |
| 07/28/2011 | US20110182910 Method of treating t cell mediated disorders |
| 07/28/2011 | US20110182901 Full length large t tumor antigen of merkel cell polyomavirus as a therapeutic target in merkel cell carcinoma |
| 07/28/2011 | US20110182897 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
| 07/28/2011 | US20110182891 Pharmaceutical dosage form comprising polymeric carrier composition |
| 07/28/2011 | US20110182889 Compositions and methods for the treatment of natural killer cell related diseases |
| 07/28/2011 | US20110182875 Novel class of therapeutic protein based molecules |
| 07/28/2011 | US20110182874 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/28/2011 | US20110182873 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/28/2011 | US20110182870 Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses |
| 07/28/2011 | US20110182865 Method for Prophylaxis and Treatment of Equine Herpesvirus Type 1 Infections |
| 07/28/2011 | US20110182863 Anti-bacteria compositions |
| 07/28/2011 | US20110182858 Silibinin component for the treatment of hepatitis |
| 07/28/2011 | US20110182857 Delivery of Drugs to Mucosal Surfaces |
| 07/28/2011 | US20110182856 Inhibitors of serine proteases |
| 07/28/2011 | US20110182854 Hcv protease inhibitors |
| 07/28/2011 | US20110182852 Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| 07/28/2011 | US20110182850 Organic compounds and their uses |
| 07/28/2011 | US20110182847 Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimens |
| 07/28/2011 | US20110182832 Perfume compositions |
| 07/28/2011 | US20110182829 Methods of stimulating immune response in virally infected individuals |
| 07/28/2011 | US20110182828 C20-c21 substituted glucocorticoid receptor agonists |
| 07/28/2011 | US20110182805 Nanoparticle fabrication methods, systems, and materials |
| 07/28/2011 | US20110180430 Adjuvanted influenza vaccines including cytokine-inducing agents |
| 07/28/2011 | CA2787974A1 Immunogenic influenza composition |
| 07/28/2011 | CA2785624A1 Methods for producing amino-substituted glycolipid compounds |
| 07/27/2011 | EP2348134A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348133A1 RNA interference mediating small RNA molecules |
| 07/27/2011 | EP2348048A1 Antagonistic Anti-HTNFSF13B Human Antibodies |
| 07/27/2011 | EP2348036A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348035A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2348034A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/27/2011 | EP2347766A1 Use of TNFalpha antibodies and another drug |
| 07/27/2011 | EP2347757A1 A natural allicin tablet and preparation method thereof |
| 07/27/2011 | EP2347662A2 Kit of pharmaceutical formulations characterised by the presence of molecular oxygen |
| 07/27/2011 | EP2347654A1 Pesticidal formulations |
| 07/27/2011 | EP2346867A1 Phosphodiestarase inhibitors |
| 07/27/2011 | EP2346862A1 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents |
| 07/27/2011 | EP2346861A2 Thiophene containing analogues of fluconazole as antifungal agents and process thereof |
| 07/27/2011 | EP2346852A1 Pyrrolidin-2-ones as hdm2 ligands |
| 07/27/2011 | EP2346842A1 New amide compounds as boosters of antivirals |
| 07/27/2011 | EP2346516A2 Antimicrobial composition from copepods |
| 07/27/2011 | EP2346509A1 Inhalation of levofloxacin for reducing lung inflammation |
| 07/27/2011 | EP2346507A1 Use of quinazoline derivatives for the treatment of viral diseases |
| 07/27/2011 | EP2346501A1 Use of cationic surfactants for the inactivation of toxins |
| 07/27/2011 | EP2346330A1 Antimicrobial compositions and uses |
| 07/27/2011 | EP2346329A1 A method of inhibiting hepatitis c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds |
| 07/27/2011 | EP1937678B1 Hiv integrase inhibitors |
| 07/27/2011 | EP1912995B1 Macrocylic inhibitors of hepatitis c virus |
| 07/27/2011 | EP1907389B1 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| 07/27/2011 | EP1869037B1 Heterobicylic inhibitors of hvc |
| 07/27/2011 | EP1633396B1 Cd20 binding molecules |
| 07/27/2011 | EP1558645B1 Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation |
| 07/27/2011 | EP1435993B1 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/27/2011 | EP1419152B1 Hiv inhibiting pyrimidines derivatives |
| 07/27/2011 | EP1267891B1 Antiadhesive carbohydrates |
| 07/27/2011 | EP0904395B2 Herpes simplex virus strains |
| 07/27/2011 | CN1964979B Novel water-soluble prodrug |
| 07/27/2011 | CN1812775B Use of pentane-1,5-diol in preparing medicine for inhibiting the growth of antibiotic-resistant of bacteria |
| 07/27/2011 | CN1393222B Use of composition of sterol compounds dissolved in oil |
| 07/27/2011 | CN1309666B Polymer composition of glucuronic acid glucosan |
| 07/27/2011 | CN102137870A Antibody directed against PcrV |
| 07/27/2011 | CN102137868A Prophylactic or therapeutic agent for influenza virus infection |
| 07/27/2011 | CN102137682A Anti-hepatitis c virus composition |
| 07/27/2011 | CN102134609A Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 07/27/2011 | CN102134562A Construction and screening of rabies virus Evelyn-Rokitnicki-Abelseth (ERA) attenuated live vaccine candidate strain |
| 07/27/2011 | CN102134279A Fusion protein and encoding gene thereof as well as application of fusion protein |
| 07/27/2011 | CN102134278A Preparation of subunit vaccine for mucosal immune in circovirus genetic engineering and application thereof |
| 07/27/2011 | CN102134231A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134230A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134229A Dipeptidyl peptidase inhibitors |
| 07/27/2011 | CN102134223A Preparation and application of novel chiral 3,4-dihydro-2-alkoxyl-6-benzyl-4-oxopyrimidine (S-DABO) human immunodeficiency virus (HIV)-1 reverse transcriptase inhibitor |
| 07/27/2011 | CN102134192A Preparation method for extracting chlorogenci acid from honeysuckle and application of honeysuckle extract |
| 07/27/2011 | CN102133401A Method for preparing inactivated vaccine by using double adjuvant |
| 07/27/2011 | CN102133400A Method for removing split agent in vaccine preparation process |
| 07/27/2011 | CN102133399A Novel process for preparing influenza virus split vaccine |
| 07/27/2011 | CN102133398A Method for industrially producing animal influenza vaccine by using bioreactor |
| 07/27/2011 | CN102133379A Traditional Chinese medicine pill for treating gynecopathy |
| 07/27/2011 | CN102133372A Compound peppermint oil preparation and effects thereof |
| 07/27/2011 | CN102133366A Traditional Chinese medicine composition for treating infant acute bacillary dysentery |
| 07/27/2011 | CN102133364A External traditional Chinese medicine for treating parotitis and acute lymphadenitis |
| 07/27/2011 | CN102133361A Traditional Chinese medicine for curing aids |
| 07/27/2011 | CN102133355A Screened traditional Chinese medicine preparation for preventing and treating high fever syndrome of livestock and preparation method thereof |
| 07/27/2011 | CN102133348A Traditional Chinese medicine for treating scarflet fever |
| 07/27/2011 | CN102133336A Traditional Chinese medicine composite, and preparation method and application thereof |
| 07/27/2011 | CN102133328A Traditional Chinese medicine special for treating breast cancers |
| 07/27/2011 | CN102133315A Chinese medicinal compound preparation for resisting human papilloma virus |
| 07/27/2011 | CN102133310A Traditional Chinese medicine powder for treating damp cholera |
| 07/27/2011 | CN102133301A Method for preparing pediatric cold granules |
| 07/27/2011 | CN102133297A Chinese medicinal preparation for treating acute lymphadenitis |